Royal Bank of Canada
HARP

Royal Bank of Canada’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Royal Bank of Canada’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-80
Closed – – 7901
2023
Q3 		$0 Sell
80
-4
-5% -$30 ﹤0.01% 7894
2023
Q2 		$0 Buy
84
+24
+40% +$166 ﹤0.01% 7884
2023
Q1 		$0 Buy
+60
New +$505 ﹤0.01% 7696
2022
Q2 		– Sell
-115
Closed -$6K – 7942
2022
Q1 		$6K Sell
115
-328
-74% -$17K ﹤0.01% 7222
2021
Q4 		$34K Buy
443
+283
+177% +$19.3K ﹤0.01% 6580
2021
Q3 		$12K Buy
160
+31
+24% +$3.12K ﹤0.01% 6916
2021
Q2 		$18K Buy
129
+4
+3% +$763 ﹤0.01% 6629
2021
Q1 		$27K Sell
125
-2,767
-96% -$555K ﹤0.01% 6267
2020
Q4 		$480K Buy
2,892
+92
+3% +$14.2K ﹤0.01% 4178
2020
Q3 		$476K Buy
+2,800
New +$404K ﹤0.01% 3908
2020
Q2 		– Sell
-2
Closed – – 7013
2020
Q1 		$0 Sell
2
-54
-96% -$7.59K ﹤0.01% 7146
2019
Q4 		$8K Buy
56
+41
+273% +$6.22K ﹤0.01% 6234
2019
Q3 		$2K Buy
15
+14
+1,400% +$1.97K ﹤0.01% 6333
2019
Q2 		$0 Buy
+1
New +$116 ﹤0.01% 7301

Other funds holding HARP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada's HARP Position: Q4 2023 in Review

Royal Bank of Canada sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2023, closing a stake of 80 shares.

Royal Bank of Canada first reported a position in HARP in Q2 2019 and held it in 14 quarters. The position peaked at $480K in Q4 2020. 41 funds tracked by Wall St. Rank hold HARP as of Q4 2023.

  • Royal Bank of Canada reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 80 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2023.
  • Royal Bank of Canada first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Royal Bank of Canada's Harpoon Therapeutics, Inc. Common Stock position peaked at $480K in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.